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limited scope trial published about a year ago. The trial dealt with
patients who had an acute ST elevation, had no revascularization,
and were randomized to receive L-arginine or not.
There may be other ways to modify endothelial function and NO
bioavailability. One way, for instance, may be to up-regulate
argininosuccinate synthase, which is a specific enzyme that derives
endothelial NO synthase from citrulline. So there are ways other
than L-arginine to make the myocardial substrate more amenable
to the new therapies that we want to see become effective one
day.
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The spelling of the surname of author Walter Geißdo¨rfer was incorrect. The correct spelling is shown in the author
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